Illumina, Harvard Pilgrim Expand Access to Next-Generation Sequencing for NIPT
Illumina has signed a contract with Harvard Pilgrim Health Care to accelerate patient access to next-generation sequencing for noninvasive prenatal testing.
Read MoreSearch Results for: genetic testing
BD Launches Blood Collection Tube for Cancer, Noninvasive Prenatal Testing Applications
The plastic blood collection tube incorporates a proprietary sample stabilization additive and BD Vacutainer Hemogard technology, and was designed to ensure accurate and reproducible results in molecular diagnostic testing applications using circulating cell-free DNA.
Read More
Delivering on the Promise of NGS for Clinical Diagnostics
Presenting an evaluation of the GeneReader next-generation sequencing (NGS) system, the article assesses the performance of the system in comparison with an alternative NGS technology.
Read More
Blazing a Path to More Effective Infectious Disease Response
With a comprehensive view of a pathogen’s genome, researchers are gaining new insights for managing infectious disease outbreaks.
Read More
Anti-Drug Immune Response Testing
The experience of inflammatory bowel disease patients has established the positive association between therapeutic drug monitoring and improved clinical outcomes.
Read More